{"CAPTION FIG1.png": "'Figure 1: T&K1 phosphorylate autophagy receptors on multiple, autophagy-relevant sites. (A) Domain structure and TBK1-dependent phosphorylation sites (\\\\(\\\\log_{2}\\\\)TBK1 KDrTBK1 WT \\\\(\\\\geq\\\\) 1) of individual autophagy receptors. (B and C) Mass spectrometric parent ion scans of the peptides corresponding to pS473 and pS513 on OPTN with increased relative abundance of phosphorylated peptides in cells expressing WT TBK1.\\n\\n'", "CAPTION FIG2.png": "'Figure 2: Phosophorylated GPTN UBAN domain enhances binding to ubiquitin chains. (4) GFP immunoprecipitation of GFP-OPTN WT and indicatad mutants from HEK293T call lysates. (B and C) Indicated GST proteins were incubated with purified M1-linked (B) or K63-linked (C) tetra-Ub chains. (D) GST-OPTN WT and mutants were phosphorylated in vitro by TB&1 and subsequently incubated with purified Ub chains. Efficient phosphorylation of OPTN is indicated through an electrophoretic mobility shift. (_A_-_D_) Samples were subjected to immunoblot. Coomassie or Ponceau S staining show equal GST protein levels. (_E_) RNAP assay of recombinant mCherry-OPTN WT (**a**) or 5473E (**a**) on the surface of dIIb-conjugated beads (_Upper_). Images were taken before and after photobleaching at indicated time points (Lower). (scale bar, 10 \u03bcm.)\\n\\n'", "CAPTION FIG3.png": "'Figure 3: TBK1 activation through mitoaghay induction. (_A_, \\\\(C\\\\), and _D_) Doxy-cycline (Dax)-inducible HA-Parkin HeLa cells were preincubated with Dax for 48 h before A0VCCCP treatment for (_A_ and _D_) B0 min or (_C_) 60 min. (_B_) SH-SYSY cells were treated with AO or CCCP for the indicated time. (_C_) WT or OPTN KO HeLa cells (nos. 3 and 5) stably expressing HA-Parkin were reconstituted with empty vector or GFP-OPTN for 30 h. (_D_) Cells were transfected with PINK1 or control siRNA for 48 h before treatment and lysis. (_A_\u2013_D_) Cell lysates were subjected to immunoblot analysis with indicated antibodies. Active TBK1 was detected with a phosphospecific antibody (pTBK1 = p5172).\\n\\n'", "CAPTION FIG4.png": "'\\n\\n## References\\n\\n* [1] A. A. K. K.\\n\\n'", "CAPTION FIG5.png": "'Figure 5: OPTH translocation to mitochondria and mitophagy are enhanced by OPTN phosphomimatic mutations. (_A_ and _B_) mCherry-Parkin pentaKO cells expressing GFP-OPTN WT or mutants were treated with AO for 0.5 or 3 h and immunostained for TOM20. Quantification of cells with GFP-OPTN colocalized with TOM20. For representative images, see Figs. S6 C and D and Fig. S7 B and E. (C and D) HA-Parkin pentaKO cells expressing mt-mRNA and vector, FlagHA-OPTN WT or mutants, as indicated, were treated with AO for 3 h and analyzed by FACS for lysosomal-positive mt-mRNAemia. (_D_) Graph depicting the average percent of cells in the upper gate from FACS analysis in C (_n_ = 3). (_E_) PentaKO cells expressing GFP-OPTN WT or mutants were treated with AO for 24 h. For representative images, see Fig. S8 E and F. (F) Graph depicting the average percent of cells in the upper gate from FACS analysis of pentaKO cells expressing FHK1\u0394110-YFP-2xFKEP, mt-mRNAemia and vector, FlagHA-OPTN WT, or mutants, following treatment with tapalog for 24 h (_n_ = 3). (_G_) Representative FACS data from tapalog-treated conditions from F are shown. For \\\\(A\\\\), \\\\(B\\\\), and \\\\(E\\\\), 100 cells per condition were counted for \\\\(n\\\\) = 3 experiments. For \\\\(A\\\\), \\\\(B\\\\), \\\\(D\\\\), \\\\(E\\\\), and \\\\(F\\\\), data are presented as mean +- SD_e_*_P_ < 0.05, **_P_ < 0.01, ***_P_ < 0.005; ns, root significant. For the untreated conditions from C and G, see Fig. S8 C and G, respectively.\\n\\n'"}